Kainos Medicine, Inc. (KOSDAQ:284620)

Kainos Medicine Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	35,557	89,333	120,625	114,482	279,944	472,242
Market Cap Growth	-78.24%	-25.94%	5.37%	-59.10%	-40.72%	-
Enterprise Value	37,375	89,178	109,730	91,314	275,139	460,327
Last Close Price	1087.00	3170.00	4320.00	4100.00	11516.11	20402.55
PS Ratio	43.35	151.32	451.25	880.46	168.40	-
PB Ratio	3.72	10.91	6.32	3.40	15.42	29.00
P/TBV Ratio	12.35	69.45	11.03	4.53	24.53	39.78
EV/Sales Ratio	45.56	151.06	410.49	702.28	165.50	-
Debt / Equity Ratio	0.03	0.06	0.02	0.12	0.79	0.69
Asset Turnover	0.06	0.04	0.01	0.00	0.04	-
Quick Ratio	2.93	1.74	9.16	6.20	1.56	33.07
Current Ratio	3.54	1.93	9.50	6.41	1.67	35.41
Return on Equity (ROE)	-84.30%	-89.36%	-57.71%	-61.35%	-94.22%	-107.81%
Return on Assets (ROA)	-41.80%	-49.26%	-35.04%	-24.95%	-18.28%	-29.08%
Return on Capital (ROIC)	-46.49%	-55.47%	-36.78%	-28.78%	-23.33%	-35.84%
Earnings Yield	-30.15%	-13.65%	-12.63%	-13.87%	-5.79%	-2.42%
FCF Yield	-24.27%	-10.87%	-15.10%	-11.46%	-3.98%	-1.83%
Buyback Yield / Dilution	-4.46%	0.27%	-17.14%	-12.49%	79.08%	-5.95%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.